D. Chiche

645 total citations
28 papers, 512 citations indexed

About

D. Chiche is a scholar working on Epidemiology, Molecular Medicine and Pharmacology. According to data from OpenAlex, D. Chiche has authored 28 papers receiving a total of 512 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Epidemiology, 8 papers in Molecular Medicine and 6 papers in Pharmacology. Recurrent topics in D. Chiche's work include Antibiotic Resistance in Bacteria (8 papers), Pneumonia and Respiratory Infections (7 papers) and Antibiotics Pharmacokinetics and Efficacy (6 papers). D. Chiche is often cited by papers focused on Antibiotic Resistance in Bacteria (8 papers), Pneumonia and Respiratory Infections (7 papers) and Antibiotics Pharmacokinetics and Efficacy (6 papers). D. Chiche collaborates with scholars based in France, United States and Israel. D. Chiche's co-authors include P Géhanno, W. A. Brown, Philippe Walker, Y. Aujard, N. Brahimi, Édouard Bingen, Richard L. Leff, Margit Solymár, Ram P. Kapil and Zsolt Szakács and has published in prestigious journals such as Blood, Antimicrobial Agents and Chemotherapy and Pharmacology & Therapeutics.

In The Last Decade

D. Chiche

26 papers receiving 486 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
D. Chiche France 12 141 130 106 98 96 28 512
Yahong Peng United States 15 11 0.1× 133 1.0× 213 2.0× 97 1.0× 407 4.2× 34 815
Tracy Snyman South Africa 13 10 0.1× 137 1.1× 34 0.3× 53 0.5× 68 0.7× 29 392
Yuguang Wang China 10 24 0.2× 82 0.6× 17 0.2× 53 0.5× 65 0.7× 34 293
Peter Y. Hahn United States 14 10 0.1× 94 0.7× 160 1.5× 32 0.3× 194 2.0× 35 739
Christopher S. Little United States 10 12 0.1× 23 0.2× 331 3.1× 21 0.2× 115 1.2× 16 781
Toktam Moghiman Iran 16 20 0.1× 28 0.2× 37 0.3× 182 1.9× 86 0.9× 36 650
Paul E. Stromberg United States 14 8 0.1× 62 0.5× 33 0.3× 33 0.3× 179 1.9× 25 799
J. I. Dahlager Denmark 7 35 0.2× 26 0.2× 14 0.1× 31 0.3× 49 0.5× 18 354
Madhan Krishnan India 10 6 0.0× 71 0.5× 23 0.2× 22 0.2× 64 0.7× 39 438
Na Zang China 14 10 0.1× 188 1.4× 107 1.0× 13 0.1× 374 3.9× 56 781

Countries citing papers authored by D. Chiche

Since Specialization
Citations

This map shows the geographic impact of D. Chiche's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by D. Chiche with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites D. Chiche more than expected).

Fields of papers citing papers by D. Chiche

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by D. Chiche. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by D. Chiche. The network helps show where D. Chiche may publish in the future.

Co-authorship network of co-authors of D. Chiche

This figure shows the co-authorship network connecting the top 25 collaborators of D. Chiche. A scholar is included among the top collaborators of D. Chiche based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with D. Chiche. D. Chiche is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Garami, András, Yury P. Shimansky, Zoltán Rumbus, et al.. (2020). Hyperthermia induced by transient receptor potential vanilloid-1 (TRPV1) antagonists in human clinical trials: Insights from mathematical modeling and meta-analysis. Pharmacology & Therapeutics. 208. 107474–107474. 109 indexed citations
3.
Brown, W. A., Richard L. Leff, Andrew M. Griffin, et al.. (2017). Safety, Pharmacokinetics, and Pharmacodynamics Study in Healthy Subjects of Oral NEO6860, a Modality Selective Transient Receptor Potential Vanilloid Subtype 1 Antagonist. Journal of Pain. 18(6). 726–738. 42 indexed citations
4.
Chiche, D., W. A. Brown, & Philippe Walker. (2016). (420) NEO6860, a novel modality selective TRPV1 antagonist: results from a phase I, double-blind, placebo-controlled study in healthy subjects. Journal of Pain. 17(4). S79–S79. 10 indexed citations
5.
Bernard, E, Dominique Breilh, J.P. Bru, et al.. (2003). Is there a rationale for the continuous infusion of cefepime? A multidisciplinary approach. Clinical Microbiology and Infection. 9(5). 339–348. 13 indexed citations
6.
7.
Bègué, P, Éréa-Noël Garabédian, Catherine Bertrand, Bernard Aubert, & D. Chiche. (1998). Penetration of Ceftazidime Into Middle Ear Fluid in Children With Otitis Media With Effusion. The Laryngoscope. 108(5). 662–664.
8.
Garraffo, R., H. Drugeon, & D. Chiche. (1997). Pharmacokinetics and pharmacodynamics of two oral forms of cefuroxime axetil. Fundamental and Clinical Pharmacology. 11(1). 90–95. 5 indexed citations
9.
Géhanno, P & D. Chiche. (1995). TONSILLOPHARYNGITIS: EVALUATION OF SHORT‐TERM TREATMENT WITH CEFUROXIME AXETIL VERSUS STANDARD 10‐DAY PENICILLIN V THERAPY. International Journal of Clinical Practice. 49(1). 28–32. 2 indexed citations
10.
Aujard, Y., et al.. (1995). Comparative efficacy and safety of four-day cefuroxime axetil and ten-day penicillin treatment of group A beta-hemolytic streptococcal pharyngitis in children. The Pediatric Infectious Disease Journal. 14(4). 295–300. 63 indexed citations
11.
Thabaut, A, J Avril, Cécile Bébéar, et al.. (1995). Evolution de la sensibilité des bacilles à Gram négatif à la ceftazidime et à trois autres bêta-lactamines en milieu hospitalier de 1989 à 1993. Médecine et Maladies Infectieuses. 25. 6–19. 3 indexed citations
12.
Chiche, D., Marguerite Guiguet, Antoine Andremont, et al.. (1993). Should vancomycin be used empirically in febrile patients with prolonged and profound neutropenia? Results of a randomized trial.. PubMed. 2(5). 275–80. 21 indexed citations
13.
Gros, Vincent, Robert Farinotti, N Brion, et al.. (1992). [Pulmonary and bronchial kinetics of cefuroxime after a single 500 mg intramuscular injection].. PubMed. 40(5). 545–50. 3 indexed citations
14.
Peyramond, D., et al.. (1991). Etude du traitement antibiotique des infections respiratoires acquises en ville : céfuroxime axétil vs amoxicilline/acide clavulanique. Médecine et Maladies Infectieuses. 21. 98–102. 1 indexed citations
15.
16.
17.
Eidelman, David H., S. Bellofiore, D. Chiche, M G Cosio, & James G. Martin. (1990). Behavior of morphometric indices in pancreatic elastase-induced emphysema in rats. Lung. 168(1). 159–169. 24 indexed citations
18.
Schaison, G, et al.. (1990). [Efficacy of the combination of ceftazidime/vancomycin in the first line treatment of infection in neutropenic children].. PubMed. 38(5 ( Pt 2)). 557–60. 2 indexed citations
19.
Hugonot, R, et al.. (1990). [Ambulatory treatment with cefuroxime-axetil of infectious bronchitis in patients sixty years of age or older: comparative study of the combination of amoxicillin and clavulanic acid].. PubMed. 38(5 ( Pt 2)). 533–7. 5 indexed citations
20.
Pico, J L, D. Chiche, F. Fitoussi, et al.. (1988). [Antibiotic therapy protocol using ceftazidime 3g/day alone or in combination with vancomycin or amikacin. In febrile episodes in neutropenic patients].. PubMed. 17(37). 1968–70. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Yahong Peng Breakdown of academic impact, for papers by Tracy Snyman Breakdown of academic impact, for papers by Yuguang Wang Breakdown of academic impact, for papers by Peter Y. Hahn Breakdown of academic impact, for papers by Christopher S. Little Breakdown of academic impact, for papers by Toktam Moghiman Breakdown of academic impact, for papers by Paul E. Stromberg Breakdown of academic impact, for papers by J. I. Dahlager Breakdown of academic impact, for papers by Madhan Krishnan Breakdown of academic impact, for papers by Na Zang
Rankless by CCL
2026